Skip to main content
. 2017 Nov 9;2017(11):CD011770. doi: 10.1002/14651858.CD011770.pub2

11.1. Analysis.

11.1

Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 1 Overall incidence of block‐related adverse events.